目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Bipolar Disorder Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Bipolar Disorder Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Bipolar Disorder Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Bipolar Disorder Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Mood Stabilizer
4.3.1. Mood Stabilizer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Anticonvulsants
4.4.1. Anticonvulsant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Antipsychotic Drugs
4.5.1. Antipsychotic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Antidepressant Drugs
4.6.1. Antidepressant Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Antianxiety Drugs
4.7.1. Antianxiety Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Other Types
4.8.1. Other Types Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bipolar Disorder Market: Drug Class Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Bipolar Disorder Market: Drug Class Movement Analysis, 2023 & 2030 (USD Million)
5.3. Selective Serotonin Reuptake Inhibitor
5.3.1. Selective Serotonin Reuptake Inhibitor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Serotonin Norepinephrine Reuptake Inhibitor
5.4.1. Serotonin Norepinephrine Reuptake Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Tricyclic Antidepressant Drugs
5.5.1. Tricyclic Antidepressant Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Monoamine Oxidase Inhibitors
5.6.1. Monoamine Oxidase Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Benzodiazepines
5.7.1. Benzodiazepines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Beta Blockers
5.8.1. Beta Blockers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Other Drugs Classes
5.9.1. Other Drugs Classes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bipolar Disorder Market: Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Bipolar Disorder Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospital Pharmacies
6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Online Pharmacies
6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Bipolar Disorder Market: Regional Estimates & Trend Analysis
7.1. Bipolar Disorder Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Sweden Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Norway Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Japan Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. China Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. South Korea Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Saudi Arabia Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Bipolar Disorder Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Advanced Micro Devices
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. AstraZeneca
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Eli Lilly and Company
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. GSK plc
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Johnson & Johnson Services, Inc
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Pfizer Inc.
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. AbbVie Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Otsuka Holdings Co., Ltd.
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Bristol-Myers Squibb Company
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Teva Pharmaceutical Industries Ltd.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. Sumitomo Pharma America, Inc
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives